Lipidomics pp 271-286 | Cite as

Lipidomic Analysis of Prostanoids by Liquid Chromatography–Electrospray Tandem Mass Spectrometry

  • Anna Nicolaou
  • Mojgan Masoodi
  • Adnan Mir
Part of the Methods in Molecular Biology book series (MIMB, volume 579)


Lipidomics aim to generate qualitative and quantitative information on different classes of lipids and their species, and when applied in conjunction with proteomic and genomic assays, facilitate the comprehensive study of lipid metabolism in cellular, organ, or body systems. Advances in mass spectrometry have underpinned the expansion of lipidomic methodologies. Prostanoids are potent autacoids present in a plethora of cellular systems, known best for their intimate role in inflammation. Electrospray ionisation (ESI) allows the efficient ionisation of prostanoids in aqueous systems. ESI can be readily coupled to liquid chromatography (LC) followed by tandem mass spectrometry (MS/MS)-based detection, thus allowing the development of a potent and selective LC/ESI–MS/MS quantitative assays. The protocol we describe in this chapter outlines the steps we follow to (a) extract prostanoids from solid or liquid samples, (b) semi-purify the metabolites using solid phase extraction (c) set-up the HPLC separation using reverse phase chromatography and (d) set-up the MS/MS assay using a triple quadrupole mass spectrometer. The experimental details and notes presented here are based on the detailed protocols followed in our group.

Key words

Prostaglandins Thromboxanes Dihydro-prostaglandins Electrospray ­ionisation Tandem mass spectrometry HPLC Lipidomics 



This project has been supported in part by the Wellcome Trust Grant WT077714. We acknowledge the excellent technical support provided by Andrew Healey, Analytical Centre, University of Bradford.


  1. 1.
    Nicolaou, A. (2004) Prostanoids, Bioactive Lipids. Nicolaou, A., Kokotos, G. editors, 197–222.Google Scholar
  2. 2.
    Schaloske, R. H. & Dennis, E. A. (2006) The phospholipase A2 superfamily and its group numbering system, Biochim Biophys Acta. 1761, 1246–59.PubMedCrossRefGoogle Scholar
  3. 3.
    Smith, W. L., DeWitt, D. L. & Garavito, R. M. (2000) Cyclooxygenases: structural, cellular, and molecular biology, Annu Rev Biochem. 69, 145–82.PubMedCrossRefGoogle Scholar
  4. 4.
    Simmons, D. L., Botting, R. M. & Hla, T. (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition, Pharmacol Rev. 56, 387–437.PubMedCrossRefGoogle Scholar
  5. 5.
    Helliwell, R. J., Adams, L. F. & Mitchell, M. D. (2004) Prostaglandin synthases: recent developments and a novel hypothesis, Prostaglandins Leukot Essent Fatty Acids. 70, 101–13.PubMedCrossRefGoogle Scholar
  6. 6.
    Tai, H. H., Ensor, C. M., Tong, M., Zhou, H. & Yan, F. (2002) Prostaglandin catabolizing enzymes, Prostaglandins Other Lipid Mediat. 69, 483–93.CrossRefGoogle Scholar
  7. 7.
    Wise, H., Wong, Y. H. & Jones, R. L. (2002) Prostanoid signal integration and cross talk, Neurosignals. 11, 20–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Samad, T. A., Sapirstein, A. & Woolf, C. J. (2002) Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets, Trends Mol Med. 8, 390–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Bishop-Bailey, D., Calatayud, S., Warner, T. D., Hla, T. & Mitchell, J. A. (2002) Prostaglandins and the regulation of tumor growth, J Environ Pathol Toxicol Oncol. 21, 93–101.PubMedCrossRefGoogle Scholar
  10. 10.
    Olson, D. M. (2003) The role of prostaglandins in the initiation of parturition, Best Pract Res Clin Obstet Gynaecol. 17, 717–30.PubMedCrossRefGoogle Scholar
  11. 11.
    Battistini, B., Picard, S., Borgeat, P. & Sirois, P. (1998) Measurements of prostanoids, leukotrienes, and isoprostanes by enzyme immunoassays, Methods Mol Biol. 105, 201–7.PubMedGoogle Scholar
  12. 12.
    Kempen, E. C., Yang, P., Felix, E., Madden, T. & Newman, R. A. (2001) Simultaneous quantification of arachidonic acid metabolites in cultured tumor cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry, Anal Biochem. 297, 183–90.PubMedCrossRefGoogle Scholar
  13. 13.
    Baranowski, R. & Pacha, K. (2002) Gas chromatographic determination of prostaglandins, Mini Rev Med Chem. 2, 135–44.PubMedCrossRefGoogle Scholar
  14. 14.
    Yue, H., Strauss, K. I., Borenstein, M. R., Barbe, M. F., Rossi, L. J. & Jansen, S. A. (2004) Determination of bioactive eicosanoids in brain tissue by a sensitive reversed-phase liquid chromatographic method with fluorescence detection, J Chromatogr B Analyt Technol Biomed Life Sci. 803, 267–77.PubMedCrossRefGoogle Scholar
  15. 15.
    Turk, J., Weiss, S. J., Davis, J. E. & Needleman, P. (1978) Fluorescent derivatives of prostaglandins and thromboxanes for liquid chromatography, Prostaglandins 16, 291–309.PubMedCrossRefGoogle Scholar
  16. 16.
    Murphy, R. C., Barkley, R. M., Zemski Berry, K., Hankin, J., Harrison, K., Johnson, C., Krank, J., McAnoy, A., Uhlson, C. & Zarini, S. (2005) Electrospray ionization and tandem mass spectrometry of eicosanoids, Anal Biochem. 346, 1–42.PubMedCrossRefGoogle Scholar
  17. 17.
    Masoodi, M. & Nicolaou, A. (2006) Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry, Rapid Commun Mass Spectrom. 20, 3023–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Margalit, A., Duffin, K. L. & Isakson, P. C. (1996) Rapid quantitation of a large scope of eicosanoids in two models of inflammation: development of an electrospray and tandem mass spectrometry method and application to biological studies, Anal Biochem. 235, 73–81.PubMedCrossRefGoogle Scholar
  19. 19.
    Nithipatikom, K., Laabs, N. D., Isbell, M. A. & Campbell, W. B. (2003) Liquid chromatographic-mass spectrometric determination of cyclooxygenase metabolites of arachidonic acid in cultured cells, J Chromatogr B Analyt Technol Biomed Life Sci. 785, 135–45.PubMedCrossRefGoogle Scholar
  20. 20.
    van Meer, G. (2005) Cellular lipidomics, Embo J . 24, 3159–65.PubMedCrossRefGoogle Scholar
  21. 21.
    Balazy, M. (2004) Eicosanomics: targeted lipidomics of eicosanoids in biological systems, Prostaglandins Other Lipid Mediat. 73, 173–80.PubMedCrossRefGoogle Scholar
  22. 22.
    Serhan, C. N. (2005) Mediator lipidomics, Prostaglandins Other Lipid Mediat. 77, 4–14.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Anna Nicolaou
    • 1
  • Mojgan Masoodi
    • 1
  • Adnan Mir
    • 1
  1. 1.Division of Pharmaceutics and Pharmacological ChemistrySchool of Pharmacy, Life Sciences, University of BradfordWest YorkshireUK

Personalised recommendations